IP Verse

Syringe - EP3536310

The patent EP3536310 was granted to Novartis on Apr 28, 2021. The application was originally filed on May 30, 2013 under application number EP19161189A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3536310

NOVARTIS
Application Number
EP19161189A
Filing Date
May 30, 2013
Status
Granted And Under Opposition
Mar 26, 2021
Grant Date
Apr 28, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM & WITTKOPPJan 28, 2022HAMM & WITTKOPPWITHDRAWN
WESSJan 28, 2022SSM SANDMAIRWITHDRAWN
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBJan 26, 2022KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBWITHDRAWN

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2005121176
EXAMINATIONWO2011006877
OPPOSITIONEP0738517
OPPOSITIONEP2047877
OPPOSITIONEP2682145
OPPOSITIONJP2001340455
OPPOSITIONJP2002177388
OPPOSITIONJP2004313369
OPPOSITIONJP2012045046
OPPOSITIONJPH0725953
OPPOSITIONUS2007250017
OPPOSITIONUS2009247957
OPPOSITIONUS2012091026
OPPOSITIONUS4946441
OPPOSITIONUS5405326
OPPOSITIONUS5597530
OPPOSITIONUS5607399
OPPOSITIONUS5607400
OPPOSITIONUS5667495
OPPOSITIONUS5688252
OPPOSITIONUS7678078
OPPOSITIONUS8075535
OPPOSITIONWO2014005728
OPPOSITIONWO9955402
SEARCHDE102008005938
SEARCHEP1488818
SEARCHEP2298392
SEARCHUS2006293270
SEARCHUS4946441
SEARCHUS5181918
SEARCHUS8075535
SEARCHWO2007035621

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Andrea Wagner, "Advances in Prefilled Syringe Technology", ITP, (20070101), vol. 24, pages 73 - 75, XP055427527-
OPPOSITION- Anonym, "Fachinformation Novartis Pharma Lucentis®", (20070101), pages 1 - 5, XP055889817-
OPPOSITION- Anonymous, "Components for prefilled syringes", Dätwyler, (20111001), pages 1 - 2, XP093063222-
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION - EYLEAâ„¢ (aflibercept) Injection", Regeneron Pharmaceuticals, Inc., (20111101), pages 1 - 15, XP055895379-
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION- LUCENTIS® (ranibizumab injection)", Genentech, Inc., (20060601), pages 5 - 11, XP055895380-
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION - MACUGEN® (pegaptanib sodium injection)", Gilead Sciences, Inc., (20040101), pages 3 - 12, XP055895383-
OPPOSITION- Anonymous, "ISO 11040-5:2007 : Prefilled syringes -- Part 5: Plungers for injectables", ISO 11040-5, (20011215), pages 1 - 10, XP093063217-
OPPOSITION- Anonymous, "MATERIAL SAFETY DATA SHEET- Lucentis®", Genentech Inc., (20090522), pages 1 - 5, XP055895377-
OPPOSITION- Anonymous, "Prefilled syringes Part 4: Glass barrels for injectables Seringues préremplies ", ISO 11040-4, (20070101), pages 1 - 16, XP093003655-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents